Imatinib Unknown Status Phase 2 Trials for Melanoma Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01782508A Phase II Study of Imatinib Versus Interferon as Adjuvant Therapy in KIT-mutated Melanoma